GAATTTGAAGATAGAGACAGGTCTCATCGGGAGGAAATGG

M1
Novak et all suggest that splicing occurs at postion 2095, we were puzzled by the fact that no splice acceptor site (essential for splicing) is present. To investigate whether the reported fusion transcripts may have been amplified due to aspecific annealing of primer MI (used in their PCR), we compared its sequence with MYHll sequences directly downstream of position 1017. Interestingly, two stretches of 6 bp in the sequence of primer M1 are identical to the MYHll sequences (Fig 3) . Such an homology may, especially in heminested PCRs, lead to an aspecific annealing and consequently lead to the amplification of artifact PCR products. Moreover, the fact that the MYHl1 splice junction is detected directly upstream of primer MI (Fig 1) suggests that this primer has aspecifically annealed in this PCR.
The absence of a splice acceptor site at MYHl1 cDNA position 2095 and the homology between primer M1 and the sequence directly downstream of MYHll cDNA position 1017 suggests that the detected products are the result of reproducible PCR artifacts and hence do not represent novel CBFB-MYHl1 transcripts. We propose that the amplification of possible alternatively spliced fragments should be reproduced using additional primers and that the genomic sequence of the relevant gene(s) should be analyzed for cryptic splice sites. This work must be performed before it can be concluded that any newly identified cDNA is the result of alternative splicing.' Response van der Reijden et a1 raise an important question, because the primer M1 is widely used for the amplification of CBFB-MYHI1 fusion transcripts.' We have performed RT-PCR after optimizing the PCR conditions with a sample from a type A patient and found conditions similar to those proposed by others.' The sequences described3 were only found in l of 17 patients tested so far, arguing against technical problems. Nevertheless, the notion that no ideal splice site (AC) is present at position 2095 is puzzling, although the sequence AC (in position 2093/94) has been shown to represent a weak acceptor splice site in rare instances." To exclude unspecific annealing of primer M1 to sequences downstream of nucleotide 1017, we are currently constructing a new assay with primers 3' of M1. We agree that problems with this primer may have general implications for the standardization of the CBFB-MYH11 assay.
Apart from this technical question, we still note that two different transcripts unrelated to the primer sequence (5' of MYHll position 994) were simultaneously isolated in our patient. We are in the process of identifying the origin of one of them, which has not been found in the Genbank.
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